Date Initiated by Firm | December 11, 2019 |
Create Date | February 05, 2020 |
Recall Status1 |
Terminated 3 on September 04, 2020 |
Recall Number | Z-1095-2020 |
Recall Event ID |
84530 |
Product Classification |
Breast biopsy / localization tray - Product Code PXP
|
Product | Centurion-
P151659 BIOPSY TRAY
P243133 LATEX TUBING PACK
P243133 LATEX TUBING PACK
P243133 LATEX TUBING PACK
P261569 PACK BIOPSY
P392929 BMT-LACERATION PACK
P429589A TRAY BONE MARRO ASC LTX SAFE
P734457 SUTURE REMOVAL PACK LATEX SAFE
P751651A BIOPSY PROCEDURE PACK
P758486 PVP PREP PACK
P758486 PVP PREP PACK
P922260 ALCOHOL PREP PACK
P928310 WET PREP TRAY
P928310 WET PREP TRAY
P948416 LACERATION PACK
P966455A BREAST BIOPSY PACK-LF |
Code Information |
Product/Lot Number: P151659 BIOPSY TRAY 2019031490 P243133 LATEX TUBING PACK 2019042590 P243133 LATEX TUBING PACK 2019031990 P243133 LATEX TUBING PACK 2019022190 P261569 PACK BIOPSY 2019021490 P392929 BMT-LACERATION PACK 2018121790 P429589A TRAY BONE MARRO ASC LTX SAFE 2019012590 P734457 SUTURE REMOVAL PACK LATEX SAFE 2019031990 P751651A BIOPSY PROCEDURE PACK 2019020890 P758486 PVP PREP PACK 2019041590 P758486 PVP PREP PACK 2019031990 P922260 ALCOHOL PREP PACK 2019041580 P928310 WET PREP TRAY 2019050690 P928310 WET PREP TRAY 2019031590 P948416 LACERATION PACK 2018110990 P966455A BREAST BIOPSY PACK-LF 2018122790 |
Recalling Firm/ Manufacturer |
Centurion Medical Products Corporation 100 Centurion Way Williamston MI 48895-9086
|
For Additional Information Contact | SAME 517-546-5400 |
Manufacturer Reason for Recall | Incomplete seals on the sterile package may compromise the sterility |
FDA Determined Cause 2 | Packaging process control |
Action | Centurion issued a notification emailed to Medline Industries,
Centurion's parent company. Centurion issued mailing letters via First Class Mail beginning on 12/12/2019, letter states reason for recall, health risk and action to take: Please identify all inventory that you have within your possession and segregate it in a location where it cannot be accessed for use. 2) If you have transferred possession of this product to another individual, to another department or to another location in your organization, you are required by FDA regulations to notify them of this recall
communication. Please ask that any affected product be returned to you for collection. 3) Affected product is not to be returned to Centurion, and should be destroyed/discarded. Document the destruction of all product on the enclosed accountability record. 4) Please complete the enclosed accountability record, whether or not you have product, and fax or email at
your earliest convenience to the attention of Lisa Carpenter, Director of Quality Assurance Centurion Medical Products Corporation, (517) 546-5400 Ext.1122. |
Distribution | Nationwide
Foreign: GHANA |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|